Longitudinal Lower Airway Microbial Signatures of Acute Cellular Rejection in Lung Transplantation
Overview
Authors
Affiliations
Acute cellular rejection (ACR) after lung transplant is a leading risk factor for chronic lung allograft dysfunction. Prior studies have demonstrated dynamic microbial changes occurring within the allograft and gut that influence local adaptive and innate immune responses. However, the lung microbiome's overall impact on ACR risk remains poorly understood. To evaluate whether temporal changes in microbial signatures were associated with the development of ACR. We performed cross-sectional and longitudinal analyses (joint modeling of longitudinal and time-to-event data and trajectory comparisons) of 16S rRNA gene sequencing results derived from lung transplant recipient lower airway samples collected at multiple time points. Among 103 lung transplant recipients, 25 (24.3%) developed ACR. In comparing samples acquired 1 month after transplant, subjects who never developed ACR demonstrated lower airway enrichment with several oral commensals (e.g., and spp.) than those with current or future (beyond 1 mo) ACR. However, a subgroup analysis of those who developed ACR beyond 1 month revealed delayed enrichment with oral commensals occurring at the time of ACR diagnosis compared with baseline, when enrichment with more traditionally pathogenic taxa was present. In longitudinal models, dynamic changes in α-diversity (characterized by an initial decrease and a subsequent increase) and in the taxonomic trajectories of numerous oral commensals were more commonly observed in subjects with ACR. Dynamic changes in the lower airway microbiota are associated with the development of ACR, supporting its potential role as a useful biomarker or in ACR pathogenesis.
Beyond the organ: lung microbiome shapes transplant indications and outcomes.
Ponholzer F, Bogensperger C, Krendl F, Krapf C, Dumfarth J, Schneeberger S Eur J Cardiothorac Surg. 2024; 66(4).
PMID: 39288305 PMC: 11466426. DOI: 10.1093/ejcts/ezae338.
Immunopathology of lung transplantation: from infection to rejection and vice versa.
Righi I, Barone I, Rosso L, Morlacchi L, Rossetti V, Caffarena G Front Immunol. 2024; 15:1433469.
PMID: 39286256 PMC: 11402714. DOI: 10.3389/fimmu.2024.1433469.
Lung Transplant Outcomes Keep BUGging us: Acute Cellular Rejection and the Lung Microbiome.
Snyder M, Kitsios G Am J Respir Crit Care Med. 2024; 209(12):1423-1425.
PMID: 38564413 PMC: 11208966. DOI: 10.1164/rccm.202403-0499ED.
Longitudinal Lower Airway Microbial Signatures of Acute Cellular Rejection in Lung Transplantation.
Natalini J, Wong K, Nelson N, Wu B, Rudym D, Lesko M Am J Respir Crit Care Med. 2024; 209(12):1463-1476.
PMID: 38358857 PMC: 11208954. DOI: 10.1164/rccm.202309-1551OC.